The Scientist

» drug development and neuroscience

Most Recent

image: Top Technical Advances 2015

Top Technical Advances 2015

By | December 24, 2015

The Scientist’s choice of major improvements in imaging, optogenetics, single-cell analyses, and CRISPR

0 Comments

image: Genes’ Cycles Change with Age

Genes’ Cycles Change with Age

By | December 23, 2015

As the rhythmic expression of many genes falls out of sync in older human brains, a subset of transcripts gain rhythmicity with age.

0 Comments

image: Algal Toxin Hurts Sea Lion Memory

Algal Toxin Hurts Sea Lion Memory

By | December 16, 2015

Results could explain why the marine mammals have been stranding on the West coast in record numbers.

0 Comments

image: First Dengue Vax Approved

First Dengue Vax Approved

By | December 11, 2015

Mexico’s health ministry has OKed the vaccine for people between nine and 45 years old.

0 Comments

image: Complications of Brain Manipulations

Complications of Brain Manipulations

By | December 9, 2015

The complex connectivities of mammalian and avian brains can confound the outcomes of transient neural manipulations, researchers show.

0 Comments

image: Another Obesity Drug Trial Death

Another Obesity Drug Trial Death

By | December 2, 2015

A second patient taking an experimental medication to treat Prader-Willi Syndrome has died of blood clots.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | December 1, 2015

Welcome to the Microbiome, The Paradox of Evolution, Newton's Apple, and Dawn of the Neuron.

0 Comments

image: BRCA1 Linked to Alzheimer’s

BRCA1 Linked to Alzheimer’s

By | November 30, 2015

The cancer-related protein BRCA1 is important for learning and memory in mice and is depleted in the brains of Alzheimer’s patients, according to a study.

0 Comments

image: Cortical Census

Cortical Census

By | November 26, 2015

Scientists document the characteristics and connections of mouse neocortical neurons to establish the most detailed microcircuit map to date.

1 Comment

image: Fatal-Disease Drug in Limbo

Fatal-Disease Drug in Limbo

By | November 25, 2015

A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.

0 Comments

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. How Microbes May Influence Our Behavior
  3. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  4. Sexual Touch Promotes Early Puberty
    Daily News Sexual Touch Promotes Early Puberty

    The brains and bodies of young female rats can be accelerated into puberty by the presence of an older male or by stimulation of the genitals.

AAAS